about
NORE1B, a candidate tumor suppressor, is epigenetically silenced in human hepatocellular carcinomaDifferential effects of polymorphic alleles of FGF receptor 4 on colon cancer growth and metastasisFibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migration.Chemoradiotherapy with 5-fluorouracil/leucovorin, surgery and adjuvant chemotherapy for locally advanced rectal cancer.Relevance of MicroRNA200 Family and MicroRNA205 for Epithelial to Mesenchymal Transition and Clinical Outcome in Biliary Tract Cancer Patients.Epithelial splicing regulatory protein 1 and 2 paralogues correlate with splice signatures and favorable outcome in human colorectal cancer.Liver resection with concomitant inferior vena cava resection: experiences without veno-venous bypass.Female gender may predict response to FOLFIRINOX in patients with unresectable pancreatic cancer: a single institution retrospective review.Controversies in the oncosurgical management of liver limited stage IV colorectal cancer.Evolution of surgical microwave ablation for the treatment of colorectal cancer liver metastasis: review of the literature and a single centre experience.Myofibroblasts are important contributors to human hepatocellular carcinoma: evidence for tumor promotion by proteome profiling.Up-regulation of the fibroblast growth factor 8 subfamily in human hepatocellular carcinoma for cell survival and neoangiogenesis.FGF18 in colorectal tumour cells: autocrine and paracrine effects.Neuromuscular electrical stimulation reduces skeletal muscle protein degradation and stimulates insulin-like growth factors in an age- and current-dependent manner: a randomized, controlled clinical trial in major abdominal surgical patients.Radiological assessment of response to neoadjuvant transcatheter hepatic therapy with irinotecan-eluting beads (DEBIRI(®)) for colorectal liver metastases does not predict tumour destruction or long-term outcome.Bayesian and frequentist analysis of an Austrian genome-wide association study of colorectal cancer and advanced adenomas.Comprehensive immunohistochemical analysis of histone deacetylases in pancreatic neuroendocrine tumors: HDAC5 as a predictor of poor clinical outcome.Thermographic real-time-monitoring of surgical radiofrequency and microwave ablation in a perfused porcine liver model.Introducing the CPL/MUW proteome database: interpretation of human liver and liver cancer proteome profiles by referring to isolated primary cells.Small mesenteric hematoma following blunt abdominal trauma as early sign in computed tomography of occult small bowel perforation-report of 2 cases.Surgical techniques and strategies for the treatment of primary liver tumours: hepatocellular and cholangiocellular carcinoma.Integrating interventional oncology in the treatment of liver tumors.Randomized clinical trial of the effect of a fibrin sealant patch on pancreatic fistula formation after pancreatoduodenectomy.Indications for liver surgery in benign tumours.Exploring the surgical landscape of pancreatic neuroendocrine neoplasia in Austria: Results from the ASSO pNEN study groupHDAC-Linked "Proliferative" miRNA Expression Pattern in Pancreatic Neuroendocrine TumorsAustrian consensus guidelines on imaging requirements prior to hepatic surgery and during follow-up in patients with malignant hepatic lesionsTNM stage and grade in predicting the prognosis of operated, non-functioning neuroendocrine carcinoma of the pancreas-a single-institution experienceAssociation of IGF1 and IGFBP3 polymorphisms with colorectal polyps and colorectal cancer riskPancreatic cancer in young adults: changes, challenges, and solutionsAssociations of Oxidative Stress and Postoperative Outcome in Liver Surgery with an Outlook to Future Potential Therapeutic OptionsProgressive Oncological Surgery Is Associated with Increased Curative Resection Rates and Improved Survival in Metastatic Colorectal CancerNon-operative management of blunt hepatic and splenic injury: a time-trend and outcome analysis over a period of 17 years.Systematic review on peri-operative lactate measurements to predict outcomes in patients undergoing liver resectionEarly response evaluation during preoperative chemotherapy for colorectal liver metastases: Combined size and morphology-based criteria predict pathological response and survival after resectionIs bile leakage after hepatic resection associated with impaired long-term survival?Primary tumour location affects survival after resection of colorectal liver metastases: A two-institutional cohort study with international validation, systematic meta-analysis and a clinical risk scoreBuilding a collaboration to improve surgical research through EORTC/ESSO 1409-CLIMB study: A prospective liver metastasis database with an integrated quality assurance programA Preoperative Clinical Risk Score Including C-Reactive Protein Predicts Histological Tumor Characteristics and Patient Survival after Surgery for Sporadic Non-Functional Pancreatic Neuroendocrine Neoplasms: An International Multicenter Cohort Study
P50
Q28300321-D52C545E-9D29-4E8C-B9C6-D8E1BAB5B500Q33757125-96C5F131-A4D2-4E4F-8F71-371259A30A45Q33783047-520DB490-EB59-46C6-BB0A-910181BF1C5EQ36216917-7BE95DA4-CD97-4418-9189-7594CC89E691Q37534719-CF26466A-6F83-42D3-B28C-AF2C906CC575Q37687476-F6AD0E3C-A02F-4681-99F2-FF5BAFF06FDDQ38117053-15ED963F-2B27-4B7B-8429-108975E9C1AEQ38163814-557FB18D-B038-4312-9FAE-7A55A9785057Q38196116-A1AC2CB7-AEA0-4239-BE7F-CDEF5B363BB5Q38196360-A2DE5CEA-4F7A-4C2D-96A6-D7F66C7F580AQ39335058-73B46150-97E8-4F69-91B7-4AED0CA1A640Q39592731-605F8702-D496-424A-90A8-19F9FE8A33DEQ40077105-F6AA3CAB-52B6-4115-8071-9ED466EE2D10Q45840627-113E7DF8-AF94-42F0-9976-53CBCADC0533Q46134242-22A1E511-1A8A-4BC4-91D0-DEE425F6A916Q47144591-D4749401-3F2E-40CD-9038-17063C84DBB7Q47848421-BF272B69-8559-4A70-859E-2E2D727D9C65Q49403297-75CE4DC0-C3B2-429F-AE4E-3A970EDF2777Q51820965-4862EE28-2429-4F98-A4A7-8BC641BF1BA3Q53065933-FBE8501B-43DE-43F5-9E28-967274C715DEQ55018940-033A11FE-F97F-4B89-96C5-0FCB744ADE4DQ55133340-4C495D93-7FF2-4FF7-B602-D3BF908147B7Q55347074-1A55936C-3A68-4A3E-B829-C860DE439F4EQ55365657-415DF7A8-65D3-471E-94BD-BFDAD8D3BACBQ57161658-3C55AC77-547D-49F0-93BC-25A06A5A9F25Q57823913-D09FBEB3-0AC2-4D8A-8629-FF6B7CA1D195Q57823919-0025B62B-B995-41CB-8600-B41D26E25D70Q57824008-450E74E5-3EB9-40CC-AC34-AE658836E834Q57824023-9CFEB9CF-165D-4E1D-8B41-06F3B9712007Q64065789-F6A12D6E-A9B7-485A-B5F5-509266103A14Q64231690-42D9B940-0C53-4312-90A9-BF04BA038440Q64245471-3A658F98-1A61-4AA9-ABDB-404E46840978Q64947355-6A798604-3368-4899-A657-A68EDA8940FEQ89742785-8BE22EF1-7FFB-4D94-BFCD-33A6A880E711Q91590197-2FD5E339-D448-4490-8C5F-CD3382D96CDDQ91902144-19B68FD7-ED48-4956-9EF7-D536AD5BFF53Q92440787-4C87B4EB-B24C-4863-8E0B-7D233BEA4BB7Q92570381-E6A15049-2D5B-44F3-9AFF-954D7771FDE3Q95306137-C85A8C32-3663-4754-A753-444A226BD1D9
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
S Stättner
@ast
S Stättner
@en
S Stättner
@es
S Stättner
@nl
S Stättner
@sl
type
label
S Stättner
@ast
S Stättner
@en
S Stättner
@es
S Stättner
@nl
S Stättner
@sl
altLabel
Stättner
@en
prefLabel
S Stättner
@ast
S Stättner
@en
S Stättner
@es
S Stättner
@nl
S Stättner
@sl
P106
P1153
14008439000
P31
P496
0000-0002-5226-7597